Indefinite Delivery Contract 36C25625D0098

Award Date 8/1/25
Last Date to Order 7/31/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $415,022.25 contract has a period of performance from September 1, 2024 to August 31, 2027 and is for the provision of Roche Diagnostics' COVID-19 reagents and Cobas supplies to the VA. Roche Diagnostics has been awarded numerous...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025. Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the procurement of Ventana immunohistochemical reagents and associated laboratory equipment, supplies, and services. This single-award IDC has a potential value of $2,442,399.60 over a 5-year ordering period from March 2024 to March 2029. Under this IDC, the VA VHA Network Contracting Office 17...
The key products and services being delivered under this federal Indefinite Delivery Contract (IDC) awarded to Roche Diagnostics Corporation include a comprehensive range of in vitro diagnostic consumables, reagents, laboratory instruments, and associated medical products and services. The prime contractor, Roche Diagnostics, a foreign-owned for-profit manufacturer, has been awarded multiple task orders by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 (VISN 6)...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test...
The key points are: This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9) to Roche Diagnostics Corporation, a large business manufacturer and distributor of in-vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $991,073.55 IDC has a period of performance through September 30, 2024 and provides a vehicle for VISN 9 to acquire reagents, test kits, test sets, and...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a series of firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The total ceiling value of the IDC is $2,403,690.00, with the most recent delivery order valued at $480,738.00 and a performance period ending on September 30, 2025. The delivery orders are...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 17, to Roche Diagnostics Corporation for the provision of Roche Ventana reagents and consumables. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment and supplies to various federal agencies, including the VA, Department of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated medical products and services. The $7.4 million single-award IDC covers a 5-year ordering period from October 1, 2023 to June 30, 2028 for "CHEMISTRY REAGENTS" to support the agency's medical laboratory testing requirements....
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at up to $15,466,932.92, is for the rental of Molecular Diagnostics Analyzers and associated reagents to support the VA's laboratory testing capabilities across its healthcare facilities. Two delivery orders have been issued...
  • 36C25625D0098
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 16 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $1,990,634.10 contract is for the provision of COBAS 6800 SYSTEM, ASSAYS, REAGENTS AND SUPPLIES. It is a Firm Fixed Price Delivery Order with an ultimate completion date of July 31, 2030. Roche Diagnostics Corporation, a global leader in diagnostic solutions, holds multiple significant IDCs and Blanket Purchase Agreements across federal agencies for a wide range of laboratory equipment, testing systems, reagents, and clinical testing services that support medical research, disease detection, and patient care. This contract award enables the VA to efficiently acquire Roche's advanced medical diagnostic technologies through pre-negotiated pricing and terms, supporting healthcare delivery for veterans.

Generated 7/17/25, 5:14 PM